.png?h=360&iar=0&w=640)
Tap into our technical expertise.
The consultation paper is available via the Treasury website and can be found here: https://consult.treasury.gov.au/c2026-785923
Please note that the proposals announced in the paper are for consultation and are not final at this stage. The consultation period is open until 14 January 2027. If these changes are to be implemented they require a change of law in due course. Any of these proposals are subject to change through the consultation and legislative process.
The consultation paper details the following proposed enhancements to the IIS rules.
IIS’s can, today, offer a death benefit capped by the Capital Access Schedule (CAS). For the first half of life expectancy the maximum death benefit is equal to 100% of the amount invested. For the second half of life expectancy the maximum death benefit is a reducing amount equal to the maximum withdrawal value.
There are, however, certain limited circumstances under the current rules where a death benefit payable (plus income payments received) is less than the amount invested.
The Government has proposed that the regulations would be amended to set a floor to the CAS for immediate IIS products. The floor would be equal to the total contributed capital (i.e. the purchase price or starting balance) less the total benefit payments and earlier commutations. In effect, this would expand the CAS to allow providers to offer a ‘return of capital’ death benefit.
Under the current regulations, it is possible to purchase deferred income stream products in instalments. However, where a product is purchased in instalments after the retirement phase start day, the maximum commutation value will be lower than if the same product were purchased with a lump sum. This is because the CAS applies from when the interest is acquired, and the proportion of the remaining life expectancy starts falling from this date.
The Government has proposed that the IIS regulations would be amended to ensure the CAS appropriately calculates the declining access to each instalment. It will allow initial full access each time an instalment is paid and will decline to the life expectancy from that point in time.
The pricing and payment terms of joint life products are based on the joint life expectancy of the couple. This pricing is driven by the member of the couple with the longest life expectancy, with the joint life expectancy always being longer than either person’s life expectancy alone.
However, the life expectancy used in calculating the CAS is that of the primary beneficiary. This disadvantages a revisionary beneficiary if their life expectancy is longer than the primary beneficiary due to factors such as gender and/or age differences.
The Government has proposed that the regulations would be amended to use a simplified joint life expectancy formula for the CAS life expectancy period for joint life products. The simplified formula would take the longest of the two individual life expectancies and add a flat number of years. The number of years is based on the age difference between the couple. This would extend the period over which a lump sum commutation or death benefit remains payable but would still subject those payments to the CAS.
The proposed years uplift would be as follows:
Age difference (years) | Uplift years |
|---|---|
| 0 to 5 | 4 |
| More than 5 to 10 | 3 |
| More than 10 to 15 | 2 |
| Over 15 | 1 |
A reversionary IIS can, today, cause the reversionary spouse to exceed their transfer balance cap. In cases where the excess is greater than the maximum commutation amount allowed under the CAS, even fully commuting the reversionary IIS will not resolve the excess. The reversionary beneficiary may be required to commute other retirement phase interests to resolve the excess.
The Government has proposed that the debit and credit to a reversionary beneficiary’s transfer balance account would be equal. That is, where an IIS reverts to a beneficiary and they commute the maximum amount, the debit to their transfer balance would be equal to the credit that arose when they began receiving the IIS. This will apply regardless of how much lump sum is available under the CAS. It will not require any adjustment to the CAS and how it applies to the interest – the debit would equal the original credit even if the lump sum were a smaller amount, or nil.
The consultation paper also proposes changing the way that account-based pre-retirement IIS products are assessed for Social Security assets test purposes. Under this proposal the account balance would be used as the purchase amount, rather than the deemed balance that applies today. Transitional arrangements for members with existing products are proposed as part of these changes. Under these arrangements, the existing treatment will be preserved for payments made to IIS products before 19 November 2026.
Please note, there is no proposed change to the assets test assessment of post-retirement IIS and other lifetime income streams (not purchased with the proceeds of a pre-retirement IIS), including Challenger Lifetime Annuity and Challenger CarePlus. In the consultation paper the Government states “The Government is committed to encouraging uptake of IIS products by preserving the concessional treatment of these products under the means testing rules”.
The consultation paper also seeks stakeholder views on potential additional enhancements to help solve other problems or challenges that inhibit successful development and take up of IIS products to date. These potential enhancements include:
The consultation period is open until 14 January 2027. ChallengerTech will keep you up to date with further progress of these proposed measures as they eventuate.